203900 Sigma-AldrichBufalin - CAS 465-21-4 - Calbiochem
A cardiotonic steroid isolated from toads of Bufo species that potently inhibits ouabain-sensitive Na+,K+-ATPase activity (IC₅₀ = 1.4 nM).
More>> A cardiotonic steroid isolated from toads of Bufo species that potently inhibits ouabain-sensitive Na+,K+-ATPase activity (IC₅₀ = 1.4 nM). Less<<Sinónimos: 5β, 20(22)-Bufadienolide-3β, 14-diol
Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| CAS # | Empirical Formula |
|---|---|
| 465-21-4 | C₂₄H₃₄O₄ |
Precios y disponibilidad
| Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
|---|---|---|---|---|---|---|
| 203900-10MG |
|
Tambor de alum | 10 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 465-21-4 |
| ATP Competitive | N |
| Form | White to off-white solid |
| Hill Formula | C₂₄H₃₄O₄ |
| Chemical formula | C₂₄H₃₄O₄ |
| HS Code | 2937 29 90 |
| Reversible | N |
| Structure formula Image | |
| Quality Segment | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Ouabain-sensitive Na+,K+-ATPase activity |
| Primary Target IC<sub>50</sub> | 1.4 nM against ouabain-sensitive Na+,K+-ATPase activity |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | EI2962500 |
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Número de referencia | GTIN |
| 203900-10MG | 04055977219937 |
Documentation
Bufalin - CAS 465-21-4 - Calbiochem Ficha datos de seguridad (MSDS)
| Título |
|---|
Bufalin - CAS 465-21-4 - Calbiochem Certificados de análisis
| Cargo | Número de lote |
|---|---|
| 203900 |
Referencias bibliográficas
| Visión general referencias |
|---|
| Kurosawa, M., et al. 2000. Am. J. Physiol. 278, C500. Kawazoe, N., et al. 1999. Oncogene 18, 2413. McGowan, M.H., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1559. Watabe, M., et al. 1998. Oncogene 16, 779. Hashimoto, S., et al. 1997. Leuk. Res. 21, 875. Morris, J.F., et al. 1997. Comp. Biochem. Physiol. A Physiol. 118, 599. Brownlee, A.A., et al. 1990. Clin. Sci. 78, 169. |



